Amanote Research
Register
Sign In
P063 STE029 Overcomes EGFR-TKI Resistance in Human Lung Adenocarcinoma
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.10.080
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
December 1, 2018
Authors
L. Huang
Q. Zhou
Publisher
Elsevier BV
Related search
Acquired Resistance Mechanisms to Combination Met-Tki/Egfr-Tki Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation
Molecular Cancer Therapeutics
Cancer Research
Oncology
P3.01-002 Concurrent EGFR T790M Secondary Mutation and EMT in a Lung Adenocarcinoma Patient With EGFR TKI Drug Resistance
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI Resistance in Lung Adenocarcinoma: The Role of RELB
Oncotarget
Oncology
Trastuzumab Emtansine Delays and Overcomes Resistance to the Third-Generation EGFR-TKI Osimertinib in NSCLC EGFR Mutated Cell Lines
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Case Report: Temporal Heterogeneity of Resistance Mechanisms to EGFR-TKI Identified in a Lung Adenocarcinoma Patient With Sarcomatoid Transformation
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
EGFR-TKI and Lung Adenocarcinoma With CNS Relapse: Interest of Molecular Follow-Up
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Combined Therapy With EGFR TKI and Gambogic Acid for Overcoming Resistance in EGFR‑T790M Mutant Lung Cancer
Oncology Letters
Cancer Research
Oncology
EGFR Inhibitors in Treatment of Lung Adenocarcinoma
Research in Oncology
Hsp90 Inhibition Overcomes HGF-Triggering Resistance to EGFR-TKIs in EGFR-Mutant Lung Cancer by Decreasing Client Protein Expression and Angiogenesis
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
